Belgian company TiGenix is \u200b\u200bdeveloping Cx611 allogeneic stem cells from adipose tissue to be used against rheumatoid arthritis.
Phase 2 Randomized Trial Planned for Early 2015.
The study will include patients with rheumatoid arthritis (RA) wh...
29 May 2022, 11:18 ()